Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Werewolf Therapeutics Inc | HOWL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 5.05 | 04:16:11 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.05 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.5735 - 8.1939 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 5.05 | USD |
Werewolf Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 215.82M | 42.74M | - | 19.94M | -37.37M | -0.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Werewolf Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HOWL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.88 | 6.2404 | 5.02 | 5.63 | 122,028 | -0.83 | -14.12% |
| 1 Month | 4.77 | 6.89 | 4.77 | 5.96 | 173,312 | 0.28 | 5.87% |
| 3 Months | 6.61 | 8.1939 | 4.50 | 6.16 | 179,788 | -1.56 | -23.60% |
| 6 Months | 2.30 | 8.1939 | 2.0601 | 4.96 | 222,751 | 2.75 | 119.57% |
| 1 Year | 3.00 | 8.1939 | 1.5735 | 3.68 | 333,502 | 2.05 | 68.33% |
| 3 Years | 12.82 | 21.67 | 1.39 | 4.86 | 212,002 | -7.77 | -60.61% |
| 5 Years | 18.21 | 23.99 | 1.39 | 5.30 | 218,191 | -13.16 | -72.27% |
Werewolf Therapeutics Description
| Werewolf Therapeutics Inc is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. |
